Magnesium Diasporal 2mmol (Magnesium Sulfate Heptahydrate)

The compound releases magnesium ions that act as cofactors for many enzymes, stabilize cell membranes, and antagonize calcium‑mediated excitability. This reduces neuronal firing, relaxes smooth muscle, and supports normal cardiac electrical activity, thereby correcting electrolyte imbalance and mitigating hyperexcitability.

The specific dose and infusion rate are determined by the prescribing clinician based on the patient’s clinical condition, serum magnesium level, renal function, and therapeutic goal. Healthcare professionals adjust the regimen to achieve safe and effective magnesium concentrations.

Safety data for magnesium sulfate in pregnancy are limited, and the product is not classified in a specific pregnancy category. Clinicians should weigh potential benefits against risks and consider alternative therapies when appropriate. Breastfeeding considerations should also be discussed with a healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Magnesium Diasporal 2mmol delivers magnesium as sulfate heptahydrate, offering rapid bioavailability via injection. Compared with oral magnesium salts, it achieves higher serum levels more quickly, which is essential in acute settings such as eclampsia or severe arrhythmias. Its electrolyte profile differs from magnesium chloride or gluconate formulations, which may be chosen for different tolerability or dosing considerations.

The product should be stored at ambient temperature, below 25 °C, in its original packaging to protect from moisture and light. Do not freeze. Before administration, inspect the solution for particulate matter or discoloration and use aseptic technique as recommended for injectable medicines.

Magnesium Diasporal 2mmol is administered by a qualified healthcare professional via intramuscular injection or intravenous infusion. The route, infusion rate, and total dose are selected based on the indication, patient weight, and clinical response, with continuous monitoring of vital signs and serum magnesium levels.

Serious risks include severe hypotension, respiratory depression, hypermagnesemia leading to cardiac arrest, and profound neuromuscular blockade. Patients with renal insufficiency or existing cardiac conduction abnormalities are particularly vulnerable, and close monitoring is essential during and after administration.

Contraindications include patients with known hypersensitivity to magnesium sulfate, severe renal failure where magnesium clearance is markedly reduced, and individuals with existing hypermagnesemia. Caution is also advised for patients with myasthenia gravis or other neuromuscular disorders that could be exacerbated by magnesium.